Table Of Content

international journal of pharmaceutics International Journal of Pharmaceutics 134 (1996) 253-254 Author index Andonovski, B., see Dimitrovska, A. (134) 213 release (in vitro) from DL-PLA methadone microspheres Arends-Scholte, A.W., see te Wierik, G.H.P. (134) 27 (134) 203 Arnardottir, H.B., S.J. Sveinsson, T. Kristmundsdottir, The Dimitrovska, A., B. Andonovski, K. Stojanoski, Spectrophoto- release of clindamycin phosphate from a suspension of metric study of copper(II) ion complexes with cefaclor (134) different types of liposomes and selected topical dosages 213 forms (134) 71 Donovan, M.D., see Bhat, P.G. (134) 15 Arwidsson, H.G., see Stubberud, L. (134) 79 Dormish, J.J., see Foster, T.M. (134) 193 Asuero, A.G.,On the buffer index of a single weak monoprotic Eissens, A.C., see te Wierik, G.H.P. (134) 27 acid system (134) 1 Evora, C., see Delgado, A. (134) 203 Attwood, D., see Burns, S.J. (134) 223 Flanagan, D.R., see Bhat, P.G. (134) 15 Barnwell, S.G., see Burns, S.J. (134) 223 Foster, T.M., J.J. Dormish, U. Narahari, J.D. Meyer, M. Bell, C.L., N.A. Peppas, An apparatus to measure polymer Vrkljan, J. Henkin, W.R. Porter, H. Staack, J.F. Carpen- swelling under load (134) 167 ter, Bergsma, J., see te Wierik, G.H.P. (134) 27 Fresta, M., G. Puglisi, Biological effects of CDP-choline loaded Bhat, P.G., D.R. Flanagan, M.D. Donovan, Drug binding to long circulating liposomes on rat cerebral post-ischemic gastric mucus glycoproteins (134) 15 reperfusion (134) 89 Boersma, T., see te Wierik, G.H.P. (134) 27 Fujita, T., see Fujita, T. (134) 47 Bonhomme-Faivre, L., B. Paule, S. Urien, E. Rudant, L. Fujita, T., T. Fujita, K. Morikawa, H. Tanaka, O. Iemura, A. Bottius, D. Pradel, D. Marrot, Pharmacokinetics of all-trans Yamamoto, S. Muranishi, Improvement of intestinal ab- retinoic acid (ATRA) in patients with renal cancer concomi- sorption of human calcitonin by chemical modification with tantly treated with interferon alpha 2A (IFN) (134) 99 fatty acids: synergistic effects of acylation and absorption Bottius, L., see Bonhomme-Faivre, L. (134) 99 enhancers (134) 47 Burns, S.J., D. Corness, G. Hay, S. Higginbottom, I. Whelan, Gautam, A., see Parimoo, P. (134) 231 D. Attwood, S.G. Barnwell, An in vitro assessment of Graffner, C., see Stubberud, L. (134) 79 liquid-filled Capill® potato starch capsules with biphasic release characteristics (134) 223 Hay, G., see Burns, S.J. (134) 223 Byron, P.R., see Hindle, M. (134) 137 Henkin, J., see Foster, T.M. (134) 193 Higginbottom, S., see Burns, S.J. (134) 223 Carpenter, J.F., see Foster, T.M. (134) 193 Hindle, M., P.R. Byron, N.C. Miller, Cascade impaction Cham, T.-M., see Chuo, W.-H. (134) 247 methods for dry powder inhalers using the high flowrate Chevanne, F., see Polard, E. (134) 37 Marple-Miller Impactor (134) 137 Chuo, W.-H., T.-R. Tsai, S.-H. Hsu, T.-M. Cham, Develop- Hsu, S.-H., see Chuo, W.-H. (134) 247 ment of nifedipine-loaded albumin microspheres using a Huang, Y.-B., P.-C. Wu, H.-M. Ko, Y.-H. Tsai, Effect of statistical factorial design (134) 247 pretreatment by cardamom oil on in vivo percutaneous Clas, $.-D., see Thibert, R. (134) 59 absorption of piroxicam gel: pharmacokinetic analysis in Cliff, M.J., see Landin, M. (134) 243 rabbits (134) 183 Corness, D., see Burns, S.J. (134) 223 Huselton, C.A., F. DeGrazia, E. Stahl, D.J. Liberato, A single dose pharmacokinetic study of 13-cis retinoic acid DeGrazia, F., see Huselton, C.A. (134) 157 (Isotretinoin, Ro 04-3780) in the pregnant New Zealand Delgado, A., C. Evora, M. Llabres, Optimization of 7-day rabbit using intravenous infusion (134) 157 254 Author index Iemura, O., see Fujita, T. (134) 47 Polard, E., P. Le Corre, F. Chevanne, R. Le Verge, In vitro and in vivo evaluation of polylactide and polylactide-co- Ko, H.-M., see Huang, Y.-B. (134) 183 glycolide microspheres of morphine for site-specific delivery Koster, V.S., P.F.M. Kuks, R. Lange, H. Talsma, Particle (134) 37 size in parenteral fat emulsions, what are the true limita- Porter, W.R., see Foster, T.M. (134) 193 tions? (134) 235 Pradel, D., see Bonhomme-Faivre, L. (134) 99 Kristmundsdottir, T., see Arnardottir, H.B. (134) 71 Prasad, C.V.N., see Parimoo, P. (134) 231 Kuks, P.F.M., see Koster, V.S. (134) 235 Puglisi, G., see Fresta, M. (134) 89 Landin, M., P. York, M.J. Cliff, R.C. Rowe, A.J. Wigmore, Redgrave, T.G., see Lundberg, B.B. (134) 119 The effect of batch size on scale-up of a pharmaceutical Rowe, R.C., see Landin, M. (134) 243 granulation in a fixed bowl mixer granulator (134) 243 Rudant, E., see Bonhomme-Faivre, L. (134) 99 Lange, R., see Koster, V.S. (134) 235 Larsson, A., see Stubberud, L. (134) 79 Schefer, T., C. Mathiesen, Melt pelletization in a high shear Le Corre, P., see Polard, E. (134) 37 mixer. VII. Effects of product temperature (134) 105 Lerk, C.F., see te Wierik, G.H.P. (134) 27 Staack, H., see Foster, T.M. (134) 193 Le Verge, R., see Polard, E. (134) 37 Stahl, E., see Huselton, C.A. (134) 157 Liberato, D.J., see Huselton, C.A. (134) 157 Stojanoski, K., see Dimitrovska, A. (134) 213 Llabres, M., see Delgado, A. (134) 203 Stubberud, L., H.G. Arwidsson, A. Larsson, C. Graffner, Looze, Y., see Vincentelli, J. (134) 147 Water solid interactions II. Effect of moisture sorption and Lundberg, B.B., B.-C. Mortimer, T.G. Redgrave, Submicron glass transition temperature on compactibility of micro- lipid emulsions containing amphipathic polyethylene glycol crystalline cellulose alone or in binary mixtures with for use as drug-carriers with prolonged circulation time polyvinyl pyrrolidone (134) 79 (134) 119 Sveinsson, S.J., see Arnardottir, H.B. (134) 71 Mach, H., see Thibert, R. (134) 59 te Wierik, G.H.P., J. Bergsma, A.W. Arends-Scholte, T. Machida, Y., see Nakamura, F. (134) 173 Boersma, A.C. Eissens, C.F. Lerk, A new generation starch Manning, M.C., see Foster, T.M. (134) 193 products as excipient in pharmaceutical tablets. I. Prepara- Marrot, D., see Bonhomme-Faivre, L. (134) 99 tion and binding properties of high surface area potato Mathiesen, C., see Schefer, T. (134) 105 starch products (134) 27 Meisner, D.R., see Thibert, R. (134) 59 Talsma, H., see Koster, V.S. (134) 235 Meyer, J.D., see Foster, T.M. (134) 193 Tanaka, H., see Fujita, T. (134) 47 Miller, N.C., see Hindle, M. (134) 137 Thacharodi, D., K. Panduranga Rao, Collagen-chitosan com- Morikawa, K., see Fujita, T. (134) 47 posite membranes controlled transdermal delivery of Mortimer, B.-C., see Lundberg, B.B. (134) 119 nifedipine and propranolol hydrochloride (134) 239 Muranishi, S., see Fujita, T. (134) 47 Thibert, R., H. Mach, S.-D. Clas, D.R. Meisner, E.B. Vadas, Characterization of the self-association properties of a Nagai, T., see Nakamura, F. (134) 173 leukotriene D, receptor antagonist, MK-0476 (134) 59 Nakamura, F., R. Ohta, Y. Machida, T. Nagai, In vitro and Tsai, T.-R., see Chuo, W.-H. (134) 247 in vivo nasal mucoadhesion of some water-soluble poly- Tsai, Y.-H., see Huang, Y.-B. (134) 183 mers (134) 173 Narahari, U., see Foster, T.M. (134) 193 Urien, S., see Bonhomme-Faivre, L. (134) 99 Niazy, E.M.,Bioavailability of meclofenamate from experi- mental sustained- release microcapsules in beagle dogs Vadas, E.B., see Thibert, R. (134) 59 (134) 129 Vincentelli, J., J.-C. Viré, C. Paul, Y. Looze, Poly(ethylene glycol) derivatized prodrugs through mixed disulfide bond Ohta, R., see Nakamura, F. (134) 173 formation: preliminary report on captopril (134) 147 Viré, J.-C., see Vincentelli, J. (134) 147 Panduranga Rao, K., see Thacharodi, D. (134) 239 Vrkljan, M., see Foster, T.M. (134) 193 Parimoo, P., C.V.N. Prasad, A. Gautam, Simultaneous quan- titative determination of metronidazole and diloxanide Whelan, I., see Burns, S.J. (134) 223 furoate in a tablet preparation by difference spectroscopy Wigmore, A.J., see Landin, M. (134) 243 (134) 231 Wu, P.-C., see Huang, Y.-B. (134) 183 Paul, C., see Vincentelli, J. (134) 147 Paule, B., see Bonhomme-Faivre, L. (134) 99 Yamamoto, A., see Fujita, T. (134) 47 Peppas, N.A., see Bell, C.L. (134) 167 York, P., see Landin, M. (134) 243